The global single use bioreactors market is estimated to grow from USD 1.3 billion in the current year to USD 6.6 billion by 2035, at a CAGR of 15% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Bioreactor
- Stirred Tank Bioreactors
- Wave-Induced Bioreactors
- Other Bioreactors
Scale of Operation
- Preclinical / Clinical
- Commercial
Type of Cell Culture
- Mammalian
- Insect
- Microbial
- Viral
- Plant
- Bacterial
Type of Biologics Synthesized
- Vaccine
- Monoclonal Antibody
- Recombinant Protein
- Stem Cell
- Cell Therapy
- Gene Therapy
Application Area
- Cancer Research
- Stem Cell Research
- Tissue Engineering / Regenerative Medicine
- Drug Discovery / Toxicity Testing
- Others
End-Users
- Biopharmaceutical / Pharmaceutical Industries
- Academic / Research Institutes
Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
Single Use Bioreactors Market: Growth and Trends
Over the years, the adoption of single-use bioreactors is rising in the biopharmaceutical industry. This is primarily driven by various factors, such as cost benefits, ease of use, high throughput, simple sterilization, and contamination management. Moreover, with single-use technology, it is very easy to scale up operations without having to invest heavily in additional infrastructure. Such systems have a low footprint, are easy to transport and made up of regulatory approved materials, such as ethylene-vinyl acetate, polycarbonate, polyethylene, and polystyrene. As a result, single-use systems are preferred over conventional stainless-steel bioreactors. In fact, single-use technologies are anticipated to be adopted by ~90% of the biopharmaceutical industry over the coming years. Further, given the advantages offered by this technology, including operational flexibility, several academic institutes have also started to adopt these technologies.
Additionally, the implementation of single use systems in small scale R&D activities in the field of recombinant protein therapeutics, monoclonal antibody-based products, and cell-based products is likely to present an opportunity to the stakeholders engaged in the development of single-use bioreactors. In light of all these developments, the single-use bioreactors industry is likely to witness significant growth in the foreseen future.
Single Use Bioreactors Market: Key Insights
The report delves into the current state of the single use bioreactors market and identifies potential growth opportunities within the industry.
Some key findings from the report include:
- Currently, over 60 companies claim to offer more than 260 cutting-edge single-use bioreactors in order to cater to the rising demand for biopharmaceuticals, across the globe.
- The market is primarily characterized by the presence of well-established players that offer single-use bioreactors for processing of various cell cultures used for the production of different types of biologics.
- In pursuit of gaining a competitive edge, single-use bioreactor manufacturers are upgrading their existing capabilities and enhancing their product portfolios to achieve better, cost-effective and faster biomanufacturing.
- The growing interest of biologic manufacturers in single-use bioreactors is evident from the rise in partnership activity; more than 50% of the deals were inked specifically for stirred tank bioreactors.
- To cater to the increasing demand for biologics, a number of players have stepped up to introduce innovative and advance single-use bioreactors, establishing a strong brand position.
- Over 400 patents have been filed / granted for single-use bioreactors by various industry and non-industry players to protect the intellectual property generated within this field.
- The single-use bioreactors market is projected to grow at a CAGR of ~17%, till 2035; the forecasted opportunity is likely to be distributed across different scales of operation, types of bioreactors and types of cell cultures.
- The growing demand for different types of biologics is anticipated to drive the growth of single-use bioreactors market; Asia-Pacific is anticipated to be the fastest growing region.
Single Use Bioreactors Market: Key Segments
Currently, Stirred Tank Bioreactors Occupies the Largest Share of the Single Use Bioreactors Market
Based on the type of bioreactor, the market is segmented into stirred tank bioreactors, wave induced bioreactors and other bioreactors. At present, stirred tank bioreactors hold the maximum share within the single use bioreactors market. This trend is likely to remain the same in the near future.
Commercial Scale Segment is the Fastest Growing Segment of the Single Use Bioreactors Market During the Forecast Period
Based on the scale of operation, the market is segmented into preclinical / clinical and commercial scale. While the preclinical / clinical scale accounts for a relatively higher market share, it is worth highlighting that commercial scale is expected to witness substantial market growth in the coming years.
Mammalian Segment is Likely to Dominate the Single Use Bioreactors Market During the Forecast Period
Based on the type of cell culture, the market is segmented into mammalian, insect, microbial, viral, plant and bacterial. At present, the mammalian segment holds the maximum share of the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.
Currently, Monoclonal Antibodies Occupy the Largest Share of the Single Use Bioreactors Market
Based on the type of biologics synthesized, the market is segmented into vaccine, monoclonal antibody, recombinant protein, stem cell, cell therapy, and gene therapy. At present, monoclonal antibodies hold the maximum share of the single use bioreactors market. It is worth highlighting that single use bioreactors market for cell therapies is likely to grow at a relatively higher CAGR, during the forecast period.
Cancer Research Segment is Likely to Dominate the Single Use Bioreactors Market During the Forecast Period
Based on the application area, the market is segmented into cancer research, stem cell research, tissue engineering / regenerative medicine, drug discovery / toxicity testing and others. Currently, the cancer research segment holds the maximum share within the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.
Biopharmaceutical / Pharmaceutical Industries are Likely to Dominate the Single Use Bioreactors Market During the Forecast Period
Based on the end-users, the market is segmented into biopharmaceutical / pharmaceutical industries, academic / research institutes. At present, the biopharmaceutical / pharmaceutical industry holds the maximum share of the single use bioreactors market. This trend is likely to remain the same in the forthcoming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa. It is worth highlighting that, over the years, the market in Asia-Pacific is expected to grow at a higher CAGR.
Some Key Players in the Single Use Bioreactors Market include:
- Applikon Biotechnology
- Biolinx Labsystems
- Celartia
- Cell Culture Company
- Cellexus
- Cercell
- CESCO Bioengineering
- Cytiva
- Eppendorf
- Merck Millipore
- Pall Corporation
- PBS Biotech
- PerfuseCell
- ProlifeCell
- Sartorius Stedim Biotech
- Solaris Biotech
- Synthecon
- Thermo Fisher Scientific
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
- Founder and Chief Executive Officer, Membio
- Manager, Bioprocessing, Distek
- Quality and Products Manager, Refine Technology
- Chief Executive Officer, CerCell
- Global Director of Sales Support, CelVivo
Single Use Bioreactors Market: Research Coverage
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the single use bioreactors market, focusing on key market segments, including [A] type of bioreactor, [B] scale of operation, [C] type of cell culture, [D] type of biologics synthesized, [E] application area [F] end-users and [G] key geographical regions.
- Market Landscape: A comprehensive evaluation of various single-use bioreactors that are either commercialized or under development, considering various parameters, such as [A] type of bioreactor, [B] scale of operation, [C] typical working volume, [D] stirrer speed, [E] weight of the bioreactor, [F] advanced display / control features, [G] mode of operation, [H] type of culture, [I] type of cell culture, [J] type of biologic synthesized and [K] end-users. In addition, the chapter presents the overall market landscape of companies developing single-use bioreactors, including information on their [L] year of establishment, [M] company size, and [N] location of headquarters.
- Company Competitiveness Analysis: A comprehensive competitive analysis of single use bioreactor manufacturers, examining factors, such as supplier strength, product portfolio diversity and portfolio strength.
- Company Profiles: In-depth profiles of key single use bioreactor manufacturers based in North America, Europe, Asia-Pacific and Rest of the World, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio, [D] recent developments and [E] an informed future outlook.
- Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2007, based on several parameters, such as [A] year of agreement, [B] type of partnership (mergers / acquisitions, product / technology integration agreements, product distribution agreements, product / technology development agreements, service alliances, supply agreements, supply / distribution agreements and others), [C] focus area, [D] type of partner, [E] type of biologic synthesized, [F] type of bioreactor involved, [G] location of facility, [H] expanded bioreactor capacity and [I] most active players. This section also highlights the regional distribution of partnership activity in this market.
- Product Competitiveness Analysis: A comprehensive competitive analysis of single use bioreactors, examining factors, such as [A] supplier strength (based on company’s overall experience) and [B] product competitiveness.
- Brand Positioning Analysis: A comprehensive analysis of brand positioning for top industry players, highlighting the prevailing perceptions of their proprietary brands. This analysis covers several relevant parameters, such as [A] portfolio strength, [B] portfolio diversity, [C] years of experience, [D] number of patents and [E] number of partnerships. In addition, the framework can assist companies in determining improvement areas by identifying gaps within their existing capabilities, as well as recognizing ways to gain competitive advantage in the mid to long term.
- Patent Analysis: Detailed analysis of various patents filed / granted related to single use bioreactors based on [A] type of patent, [B] publication year, [C] application year, [D] patent jurisdiction, [E] focus area, [F] Cooperative Patent Classification (CPC) symbols, [G] type of applicant and [H] most active players (in terms of number of patents filed / granted). It also includes a patent benchmarking analysis and a detailed valuation analysis.
- Case Study 1: A case study on the key technological innovations, such as built-in system control sensors, advanced alarm systems, electronic-log records, touch screens, real-time tracking, remote monitoring and advanced mixing technologies, that have been introduced in the single use bioreactors industry. It also highlights the ongoing progression of automation in single use bioreactors for better bioprocess development.
- Case Study 2: A comprehensive evaluation of various bioprocess controllers and automation systems, considering various parameters, such as [A] scale of operation, [B] key features, [C] compatibility with bioreactor system, [D] type of bioprocess, and [E] type of process controlled. In addition, the chapter presents details of companies involved in the development of bioprocess control software, and upstream and downstream controllers, including information on their respective [F] year of establishment, [G] company size, and [H] location of headquarters.
- SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution. Further, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
Key Questions Answered in this Report
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What kind of partnership models are commonly adopted by industry stakeholders?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Reasons to Buy this Report
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Additional Benefits
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 10% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Applikon Biotechnology
- Biolinx Labsystems
- Celartia
- Cell Culture Company
- Cellexus
- Cercell
- CESCO Bioengineering
- Cytiva
- Eppendorf
- Merck Millipore
- Pall Corporation
- PBS Biotech
- PerfuseCell
- ProlifeCell
- Sartorius Stedim Biotech
- Solaris Biotech
- Synthecon
- Thermo Fisher Scientific
Methodology
LOADING...
